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Abstract
Background: In clinical practice and in clinical trials, echocardiography and scintigraphy are used the most for
the evaluation of global left ejection fraction (LVEF) and left ventricular (LV) volumes. Actually, poor quality
imaging and geometrical assumptions are the main limitations of LVEF measured by echocardiography. Contrast
agents and 3D echocardiography are new methods that may alleviate these potential limitations.
Methods: Therefore we sought to examine the accuracy of contrast 3D echocardiography for the evaluation of
LV volumes and LVEF relative to MIBI gated SPECT as an independent reference. In 43 patients addressed for
chest pain, contrast 3D echocardiography (RT3DE) and MIBI gated SPECT were prospectively performed on the
same day. The accuracy and the variability of LV volumes and LVEF measurements were evaluated.
Results: Due to good endocardial delineation, LV volumes and LVEF measurements by contrast RT3DE were
feasible in 99% of the patients. The mean LV end-diastolic volume (LVEDV) of the group by scintigraphy was 143
± 65 mL and was underestimated by triplane contrast RT3DE (128 ± 60 mL; p < 0.001) and less by full-volume
contrast RT3DE (132 ± 62 mL; p < 0.001). Limits of agreement with scintigraphy were similar for triplane andfull-
volume, modalities with the best results for full-volume. Results were similar for calculation of LV end-systolic
volume (LVESV). The mean LVEF was 44 ± 16% with scintigraphy and was not significantly different with both
triplane contrast RT3DE (45 ± 15%) and full-volume contrast RT3DE (45 ± 15%). There was an excellent
correlation between two different observers for LVEDV, LVESV and LVEF measurements and inter observer
agreement was also good for both contrast RT3DE techniques.
Conclusion: Contrast RT3DE allows an accurate assessment of LVEF compared to the LVEF measured by
SPECT, and shows low variability between observers. Although RT3DE triplane provides accurate evaluation of
left ventricular function, RT3DE full-volume is superior to triplane modality in patients with suspected coronary
artery disease.
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Background
The determination of the global LV function and cardiac
volumes remains one of the most important issues in the
everyday practice of the cardiologist because these meas-
urements are shown to correlate most strongly with prog-
nosis among patients with cardiac disease [1,2]. Due to its
high spatial and temporal resolution, 2D echocardiogra-
phy (2DE) is widely used for the determination of global
and regional ventricular function. However, its accuracy is
limited significantly when underlying cardiac pathology is
present [3-5]. The advantage of scintigraphy is that the
acquisition of the images is much less observer-dependent
than in echocardiography. Moreover, non-echocardi-
ogaphic methods work in patients in whom ultrasound
methods fall because of a poor acoustic window. Scintig-
raphy and angiography have been validated in numerous
trials. Nuclear gated blood-pool imaging is considered the
gold standard for the assessment of LV function because it
provides a 3 D data set. Scintigraphy is reproducible and
reliable for the assessment of parameters of global cardiac
function (LVEF, LVESV and LVEDV) and widely available,
but is associated with limitations that also preclude rou-
tine application [6,7] and is relatively costly for the data
obtained. It is now used more as a reference method to
validate new echocardiographic methods [8]. In clinical
practice there is no real alternative to echocardiography,
which is widely available, portable and repeatable.
RT3DE technology, which has recently become widely
available, allows fast acquisition from a single acoustic
window of dynamic data that encompass the entire heart.
Using 3D imaging, less geometrical assumptions are
made, and thus RT3DE should be more useful for the
assessment of left ventricular size and function. Several
recent studies have demonstrated the potential improve-
ments in the evaluation of global LV function from
RT3DE data [9]. One important limitation of echocardi-
ography remains the inability to define the endocardial
border in a subset of patients with poor image quality,
therefore limiting the feasibility of LVEF measurements
and its reproducibility in a non selected population [10].
Over the past decade, the use of contrast agents has been
successfully applied to overcome this limitation [11] with
2DE and more recently with RT3DE. To date, this combi-
nation of contrast with RT3DE has been compared to
unenhanced RT3DE or with magnetic resonance imaging
(MRI) [12,13], but no data regarding comparison with
MIBI gated SPECT are available. MRI can not be used in
daily clinical practice and in large clinical trials. Only
echocardiography and nuclear cardiology permit the
determination of both parameters on a regular basis.
Therefore, we aimed to compare the feasibility and the
accuracy of contrast enhanced RT3DE triplane and RT3DE
full-volume with MIBI gated SPECT, as an independent
reference, for the evaluation of the LVEF and cardiac vol-
umes.
Methods
Study design
We prospectively recruited 43 consecutive patients
addressed for chest pain to the echocardiography labora-
tory for measurement of LV volumes and LVEF. After
exclusion of one patient with poor echocardiographic
images and three with atrial fibrillation, a study group of
38 patients (20 men, 18 women; age, 70 ± 11 years) who
underwent contrast RT3DE and MIBI gated SPECT during
the same day within one hour.
Real-time three-dimensional echocardiography
A. Triplane
Enhanced contrast studies were performed with a com-
mercially available echocardiographic platform (VIVID 7,
GE Vingmed Ultrasound, Horten, Norway), equipped
with a 3V-probe for triplane acquisition in harmonic
mode. Patients were scanned in the left lateral decubitus
position, from the apical window. Care was taken to visu-
alise the true LV apex allowing simultaneous acquisition
of the apical four-, two- and three-chamber views. (Figure
1) Cineloops of 3 cardiac cycles of the triplane quad-
screen, were digitally stored in raw data format. Sector size
and depth were adjusted to achieve optimal visualisation
of the six LV walls at the highest possible frame rate. Dur-
ing post-processing, the triplane dataset was frozen in end
diastole and the endocardial border was manually traced
in the apical four-, two- and three-chamber, views respec-
tively. To enhance endocardial border delineation, the
software allows separate visualisation of the three apical
views. Then, using the same heartbeat, the triplane dataset
was frozen in end systole and again the endocardial bor-
der was manually traced in the apical four-, two- and
three-chamber views. Papillary muscle was systematically
left within the cavity. A 3-D LVEDV and LVESV was gener-
ated automatically by the software and LV volumes and
ejection fraction were reported accordingly [see Addi-
tional file 1]. The measurements from the 3 consecutive
beats recorded were averaged.
B. Full-volume
RT3DE full-volume images with contrast were also
obtained from an apical window with the patient in the
same position. Images were gathered over 4 cardiac cycles
using the same matrix-array ultrasonographic transducer.
Measurements of RT3DE volumes were performed offline
as previously described (4D Analysis, Tomtec Gmbh, Ger-
many) [14] and compared with the measurements
obtained with both gated SPECT and RT3DE triplane
imaging [see Additional file 2].Cardiovascular Ultrasound 2009, 7:27 http://www.cardiovascularultrasound.com/content/7/1/27
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Contrast protocol
The commercial available contrast agent Sonovue®
(Bracco Diagnostics, Inc.) is an aqueous suspension of sta-
bilized SF6 microbubbles. The size of these microbubbles
is between 1 and 10 μm, and their number is between 2
and 5 × 108 per mL. The solution was prepared according
to the manufacturer's instructions and injected using a
dedicated pump (Bracco, Italy) at an initial rate of 0.5 ml/
min. The rate of bolus infusion was adapted for optimal
visualization of endocardial border definition. The con-
trast-enhanced imaging was performed using predefined
settings (low mechanical index < 0.5, gain 60%, compres-
sion 15%).
Gated SPECT imaging
LVEF was calculated from the gated SPECT images using
the full automatic program developed at Cedars-Sinai
(GS-Quant, Siemens, Inc.).[15]
Myocardial perfusion SPECT gated in eight time bins were
acquired 60 min after the injection of 925 MBq techne-
tium-99m labelled sestamibi (MIBI) at rest using a dual-
head gamma camera (ADAC Laboratories, Milpitas, Cali-
fornia, U.S.A.) Detailed imaging and data processing have
been reported previously [16]. The software algorithm
segments the LV, estimates, and displays epicardial and
endocardial surfaces and the valve plane for all images in
the cardiac cycle and calculates the LVEDV and LVESV and
derives the LVEF. Physicians interpreting the gated SPECT
studies were blinded to the RT3DE results.
Statistical analysis
Data are presented as mean ± SD. Two-tailed t-tests were
used where appropriate. Linear regression with Pearson's
correlation coefficient was used to assess correlations
between RT3DE and MIBI gated SPECT data. Bland-Alt-
man analysis was used to express agreement between
RT3DE and gated-SPECT measurements. A subgroup of
20 randomly selected patients was studied for interob-
server variability, which was determinated by using the
same set of contrast RT3DE images measured by two sep-
arate sonographers. The interobserver variability in quan-
Example of contrast RT3DE triplane showing the apical three orthogonal cutting planes Figure 1
Example of contrast RT3DE triplane showing the apical three orthogonal cutting planes.Cardiovascular Ultrasound 2009, 7:27 http://www.cardiovascularultrasound.com/content/7/1/27
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titative RT3DE LV volumes and LVEF was assessed by
calculating the linear regression with Pearson's correlation
coefficient and the limits of agreement between measure-
ments made by use of Bland-Altman analysis between the
two different observers [17]. A value of p < 0.05 was con-
sidered statistically significant. All statistical analyses were
performed using SPSS (version 14.0) statistical software
(SPSS Inc, Chicago, IL).
Results
The baseline characteristics of the patients are summa-
rized in Table 1. Most of the patients had a previous his-
tory of coronary artery disease.
Left ventricular volumes and LVEF
The mean LVEDV of the group by scintigraphy was
143+65 mL (range: 66–323 mL) and was underestimated
by triplane contrast RT3DE (128 ± 60 mL; p < 0.001) and
less by full-volume contrast RT3DE (132+62 mL; p <
0.001). Limits of agreement with scintigraphy were simi-
lar for triplane andfull-volume modalities with the best
results for full-volume (mean of the difference ± 2 SD: 5.2
± 12.2). Results were similar for calculation of LVESV. By
scintigraphy, the mean LVESV was 88 ± 62 mL (range: 26–
264 mL) versus 75 ± 54 mL with triplane (p < 0.001) and
80 ± 57 mL with full-volume (p < 0.001). The mean LVEF
was 44 ± 16% with scintigraphy and was not significantly
different with both triplane contrast RT3DE (45 ± 15%)
and full-volume contrast RT3DE (45 ± 15%).
Accuracy and variability of contrast enhanced 3D 
echocardiography
The correlation between contrast RT3DE triplane and full-
volume with gated SPECT and the Bland-Altman plots are
shown in Figure 2 and Figure 3 respectively. All measure-
ments were strongly and significantly correlated for the
different parameters when compared to scintigraphy. For
LVEDV, LVESV and LVEF, the agreement was also good for
both echocardiographic imaging modalities.
Triplane contrast RT3DE has shown a good correlation
between two different observer's measurements for
LVEDV (r2 = 0.9; p < 0.0001), LVESV (r2 = 0.9; p < 0.0001)
and LVEF (r2 = 0.9; p < 0.0001) respectively. Inter-observer
agreement was also good for LVEDV (mean of the differ-
ence ± 2 SD: -0.09 ± 6.1), LVESV (mean of the difference
± 2 SD:-0.3 ± 7.8) and LVEF (mean of the difference ± 2
SD:-0.8 ± 7).
Regarding full-volume contrast RT3DE, there was also an
excellent correlation between two different observer's
measurements for LVEDV (r2 = 0.9; p < 0.0001), LVESV (r2
= 0.9; p < 0.0001) and LVEF (r2 = 0.9; p < 0.0001) respec-
tively. Inter observer agreement was also good LVEDV,
LVESV and LVEF (mean of the difference ± 2 SD:-1.1 ± 2.8,
-0.6 ± 2.5, -0.1 ± 2.3 respectively).
Discussion
The results of the present study indicate that the combina-
tion of contrast with RT3DE triplane or full-volume
allows the measurements of LV volumes and global systo-
lic function in nearly all patients from an unselected pop-
ulation regarding baseline image quality. Our data further
indicate an excellent accuracy of contrast RT3DE with a
good correlation for LV volumes and LVEF assessment
compared with MIBI gated SPECT, used as an independ-
ent reference. Although RT3DE triplane provides accurate
evaluation of left ventricular function, RT3DE full-volume
is superior to triplane modality in patients with suspected
coronary artery disease. Finally, RT3DE with contrast
shows a high interobserver agreement.
Limitations of unhanced imaging
The main limitations of 2DE are tangential scanning
yielding to LV foreshortening, low lateral resolution and
geometric assumptions particularly in distorted ventricles.
Other limitations are the low test-retest reproducibility
and the underestimation of volumes compared to cinean-
giography, radionuclide ventriculography and MRI, espe-
cially for largest volumes. Using fundamental imaging,
approximately 20% of resting echos demonstrate inade-
quate endocardial definition [18], defined as ≥ 2 segments
not seen at baseline. While native tissue harmonic imag-
ing enables better endocardial definition than standard
fundamental imaging and reduces the number of patients
with inadequate studies to 5–10%, contrast LV opacifica-
tion still confers benefit over harmonic imaging [19].
Limitations of unhanced 3D echocardiography
RT3DE compares favourably with reference methods
[20,21]. However, when described in detail in the meth-
ods sections of these studies, the LVEF and cardiac vol-
Table 1: Clinical characteristics of the patient
N = 38 (%)
Age (years) 70 ± 11
Male 20 (52%)
Hypertension 27 (71%)
Hypercholesterolemia 28 (73%)
Diabetes mellitus 6 (15%)
Tobacco use 15 (39%)
Prior myocardial infarction 8 (21%)
Prior percutaneous coronary intervention 25 (65%)
Prior coronary artery bypass surgery 19 (50%)
Acetylsalicylic acid 20 (52%)
Clopidogrel 11 (28%)
Statin 16 (42%)
Beta-blockers 12 (31%)
Angiotensin-Converting Enzyme Inhibitors 18 (47%)
Angiotensin receptors blockers 13 (34%)Cardiovascular Ultrasound 2009, 7:27 http://www.cardiovascularultrasound.com/content/7/1/27
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umes assessed by RT3DE were obtained among patients
with "good" image quality and a percentage of patients
(range 15 to 20%) were excluded because of an inade-
quate endocardial border delineation by the RT3DE
[12,13,22-25]. A recent study comparing RT3DE without
contrast with gated SPECT showed that poor echocardio-
graphic image quality was associated with greater bias and
larger confidence intervals [26]. In the present study, with
the use of contrast, only 1% of the RT3DE were considered
inadequate because we could not identify the endocardial
border sufficiently well to render a meaningful manual
tracing. This percentage of patients excluded for inade-
quate image quality is dramatically lower than previously
published experience with RT3DE without contrast (range
4.3–13.8%) [9,13,27,28]. Moreover, the addition of con-
trast to 3D echocardiography has been shown to improve
reproducibility and accuracy of this method when com-
pared to unhanced 3D echocardiography relative to MRI
[29].
Gated SPECT compared to 3D echocardiography
Although MRI has been extensively validated and is
known to give accurate estimates of left ventricular vol-
umes and function, MRI is not readily available in most
institutions; it is expensive, time consuming and it is not
feasible in all patients [12,13,22-25,30]. Previous investi-
gators have shown that MIBI gated SPECT imaging is a
highly accurate method to determine these volumes [31-
33]. Our results are strongly correlated with measure-
ments derived from MIBI gated SPECT. Similar to report
by other investigators, we found that ESV and EDV by con-
trast RT3DE mildly underestimate LV volumes as com-
pared to the reference method [3,19,20]. These
discrepancies may be accounted for by not including the
volume under the mitral valve leaflets in the contrast
RT3DE calculation of volumes and a possible overestima-
tion of volumes by gated SPECT. The mitral valve opening
and closure and consequently the timing of EDV and ESV
can also be more difficult to determine when contrast is
Correlations and Bland Altman plots for EDV, ESV and LVEF with both RT3DE triplane and MIBI gated SPECT Figure 2
Correlations and Bland Altman plots for EDV, ESV and LVEF with both RT3DE triplane and MIBI gated 
SPECT.Cardiovascular Ultrasound 2009, 7:27 http://www.cardiovascularultrasound.com/content/7/1/27
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present. The underestimation of LV volumes with contrast
RT3DE is less than expected, and the correlation with
gated SPECT measurements is strong. This may be due to
increase in image quality and to LV volumes increase sec-
ondary to use of contrast. A previous study has shown that
the use of ultrasound contrast enhancement results in a
sizable and significant increase in both end-diastolic and
end-systolic RT3DE LV volumes, compared with non-con-
trast measurements [34]. The endocardium consists of
sponge-like trabeculae with blood flowing in between
them, the consequence of this anatomical fact appears to
be largely underappreciated in quantitative RT3DE analy-
sis. The intertrabecular space may actually comprise a
large part of the true LV cavity volume – a volume that tra-
ditionally remains undetected, as the LV trabeculae would
be indistinguishable from the LV wall if contrast were not
used. However, other authors have reported underestima-
tion of LV volumes with contrast [35]. Although we didn't
compare our LV volumes measurements with or without
contrast, our data indicate that LV volumes measurements
with contrast RT3DE still underestimated volumes com-
pared to the MIBI gated SPECT.
Limitations of 3D echocardiographic modalities
The main limitations of full-volume RT3DE are the need
for expertise, the off-line and time consuming analysis
and the possible undersampling secondary to low frame
rate (potential underestimation of LVEDV and overesti-
mation of LVESV). Given that the images were obtained at
rest, the temporal resolution of contrast RT3DE was simi-
lar to that obtained with MRI and superior compared to
gated SPECT.
On another hand, full-volume dataset may be insufficient
to capture the entire LV volume of a large heart but this
might be alleviated by ongoing technical improvements."
Correlations and Bland Altman plots for EDV, ESV and LVEF with both RT3DE full-volume and MIBI gated SPECT Figure 3
Correlations and Bland Altman plots for EDV, ESV and LVEF with both RT3DE full-volume and MIBI gated 
SPECT.Cardiovascular Ultrasound 2009, 7:27 http://www.cardiovascularultrasound.com/content/7/1/27
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Compared to a previous study [26] for a group of patients
who seem to have similar distribution of ventricular vol-
umes, the average biases for the end diastolic volumes
appeared to be much greater with the triplane modality.
The biases would be expected to be lesser in this group
compared to this earlier study because of the use of con-
trast echocardiography. This was probably due to the rel-
atively small number of imaging planes used to record the
volumes. The bias was less important compared to gated
SPECT when using RT3DE full-volume measurements.
Our study also showed that contrast RT3DE triplane was
a reproducible technique with an excellent correlation
between two different observer's measurements which
confirms previous studies about RT3DE showing that this
technique is less dependent on operator skills, can help to
compensate for sonographer inexperience and has a
higher reproducibility than 2DE [16-18]. Contrast RT3DE
full-volume has been shown to be superior to RT3DE tri-
plane for reducing the scatter and by improving accuracy
and reproducibility [36]. Although it was confirmed in the
present study, it remains more time consuming, requires
additional software and gating. The latter may limit appli-
cation of this technique in patients with arrhythmias and
requires stitching of data collected during four consecu-
tive beats. Although less accurate than full-volume, con-
trast RT3DE triplane has sufficient accuracy to provide a
close approximation for a valuable measurement of vol-
umes and LV function compared to gated SPECT. A new
generation of echo machines has been recently released,
allowing the acquisition of the full-volume data set in one
beat with automated delineation of the endocardial bor-
der. Pending validation, this should be the standard for
measuring LV volumes and LVEF in the upcoming years.
Clinical utility
The evaluation of LV volumes and LVEF is sought for
major decisions in cardiology. The combination of con-
trast with RT3DE offers the unique opportunity to allevi-
ate the main limitations of 2DE and to be used in
unselected population. RT3DE does not have significant
limitations in clinical application such as exposure to ion-
izing radiation (the dose of a technetium sestamibi scan
corresponds to 500 chest x rays and to an extra risk of can-
cer of about 1 in 2000 exposed patients for one single
examination), exposure to radiographic contrast material,
cost, invasive nature, or contraindications such as the
presence of implanted metallic objects or claustrophobia.
Moreover, contrast RT3DE has the advantage to be a port-
able and versatile technique with a high spatial and tem-
poral resolution that can be performed at bedside.
Therefore it is the ideal tool making serial study of LV vol-
umes and LVEF practical.
Limitations of the study
Contrast was used in all patients without any selection.
Even patients with good quality image had received con-
trast. We did not analyze the impact of contrast in func-
tion of baseline image quality. Therefore, the requirement
for contrast for all RT3DE studies can not be extrapolate
from the present study. However, it has been shown that
increase of inter-observer reproducibility with contrast
enhanced left ventricular opacification was not restricted
to patients with poor baselineimage quality (11), so the
benefit of contrast may not completely relate to improved
endocardial resolution. The avoidance of off-axis image
projections with contrast enhanced left ventricular opaci-
fication in patients with good resting images likely
explains the better accuracy of LV and LVEF calculations
with RT3DE.
The study patients were all in sinus rhythm; thus, the
results cannot be generalized to patients with arrhythmia.
The reason for excluding these patients was mainly the
risk of inadequate gated SPECT quality.
Conclusion
Contrast 3D echocardiography allows an accurate assess-
ment of LVEF compared to the LVEF measured by SPECT,
and is reproducible. Although RT3DE triplane provides
accurate assessment of left ventricular function, RT3DE
full-volume is superior to triplane modality. However,
both methods have sufficient accuracy to provide a close
approximation for a valuable measurement of volumes
and LV function compared to gated SPECT in patients
with suspected coronary artery disease. This technique
provides a quick, inexpensive, portable and accurate alter-
native for LV size and function analysis and can be consid-
ered as the method of choice for the daily measurement of
LVEF, especially when serial measurements are required.
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